Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zonisamide 200mg capsules
0408010ADAAAIAI
|
Zonisamide | Zonisamide | Central Nervous System | No data available |
|
Zopiclone 1.88mg/5ml oral suspension
0401010Z0AAAGAG
|
Zopiclone | Zopiclone | Central Nervous System | No data available |
|
Zopiclone 5mg/5ml oral suspension
0401010Z0AAABAB
|
Zopiclone | Zopiclone | Central Nervous System | No data available |
|
Zotepine 100mg tablets
0402010ACAAACAC
|
Zotepine | Zotepine | Central Nervous System | No data available |
|
Zotepine 25mg tablets
0402010ACAAAAAA
|
Zotepine | Zotepine | Central Nervous System | No data available |
|
Zotepine 50mg tablets
0402010ACAAABAB
|
Zotepine | Zotepine | Central Nervous System | No data available |
|
Zubsolv 11.4mg/2.9mg sublingual tablets
0410030B0BCADAJ
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 2.9mg/0.71mg sublingual tablets
0410030B0BCABAH
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 5.7mg/1.4mg sublingual tablets
0410030B0BCACAI
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 8.6mg/2.1mg sublingual tablets
0410030B0BCABAF
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zuclopenthixol acetate 100mg/2ml inj ampoules
040201010AAABAB
|
Zuclopenthixol acetate | Zuclopenthixol acetate | Central Nervous System | No data available |
|
Zypadhera 210mg inj vials
0402020ACBBAAAA
|
Zypadhera | Olanzapine embonate | Central Nervous System | No data available |
|
Zypadhera 300mg inj vials
0402020ACBBABAB
|
Zypadhera | Olanzapine embonate | Central Nervous System | No data available |
|
Zypadhera 405mg inj vials
0402020ACBBACAC
|
Zypadhera | Olanzapine embonate | Central Nervous System | No data available |
|
Zyprexa 10mg powder for solution for injection vials
040201060BBAIAN
|
Zyprexa | Olanzapine | Central Nervous System | No data available |
|
Zytram SR 100mg tablets
040702040BVACAC
|
Zytram SR | Tramadol hydrochloride | Central Nervous System | No data available |
|
Zytram SR 150mg tablets
040702040BVAAAD
|
Zytram SR | Tramadol hydrochloride | Central Nervous System | No data available |
|
Zytram SR 200mg tablets
040702040BVADAE
|
Zytram SR | Tramadol hydrochloride | Central Nervous System | No data available |
|
Zytram SR 75mg tablets
040702040BVABAP
|
Zytram SR | Tramadol hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.